Free Trial

AVANOS MEDICAL (AVNS) Competitors

AVANOS MEDICAL logo
$10.74 -0.05 (-0.46%)
Closing price 08/13/2025 03:59 PM Eastern
Extended Trading
$10.74 +0.00 (+0.05%)
As of 08/13/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AVNS vs. EYE, LMAT, CNMD, LQDA, ENOV, AORT, CDRE, NVCR, SSII, and ESTA

Should you be buying AVANOS MEDICAL stock or one of its competitors? The main competitors of AVANOS MEDICAL include National Vision (EYE), LeMaitre Vascular (LMAT), CONMED (CNMD), Liquidia Technologies (LQDA), Enovis (ENOV), Artivion (AORT), Cadre (CDRE), NovoCure (NVCR), SS Innovations International (SSII), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.

AVANOS MEDICAL vs. Its Competitors

National Vision (NASDAQ:EYE) and AVANOS MEDICAL (NYSE:AVNS) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

National Vision has a net margin of -0.75% compared to AVANOS MEDICAL's net margin of -66.89%. AVANOS MEDICAL's return on equity of 6.16% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision-0.75% 3.56% 1.49%
AVANOS MEDICAL -66.89%6.16%4.57%

95.2% of AVANOS MEDICAL shares are held by institutional investors. 2.7% of National Vision shares are held by insiders. Comparatively, 2.6% of AVANOS MEDICAL shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

National Vision currently has a consensus price target of $24.73, suggesting a potential upside of 6.49%. Given National Vision's stronger consensus rating and higher probable upside, analysts plainly believe National Vision is more favorable than AVANOS MEDICAL.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.60
AVANOS MEDICAL
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, National Vision had 9 more articles in the media than AVANOS MEDICAL. MarketBeat recorded 12 mentions for National Vision and 3 mentions for AVANOS MEDICAL. National Vision's average media sentiment score of 1.01 beat AVANOS MEDICAL's score of -0.18 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
3 Very Positive mention(s)
4 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AVANOS MEDICAL
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

National Vision has higher revenue and earnings than AVANOS MEDICAL. National Vision is trading at a lower price-to-earnings ratio than AVANOS MEDICAL, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.82B1.01-$28.50M-$0.18-129.00
AVANOS MEDICAL$687.80M0.72-$392.10M-$10.07-1.07

National Vision has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, AVANOS MEDICAL has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500.

Summary

National Vision beats AVANOS MEDICAL on 12 of the 16 factors compared between the two stocks.

Get AVANOS MEDICAL News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVNS vs. The Competition

MetricAVANOS MEDICALMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$500.68M$6.97B$5.54B$20.85B
Dividend YieldN/A1.31%4.62%3.60%
P/E Ratio-1.0725.2030.1328.50
Price / Sales0.7268.92462.1681.45
Price / Cash0.9121.6737.7523.46
Price / Book0.645.698.495.45
Net Income-$392.10M$176.29M$3.26B$994.60M
7 Day Performance0.23%4.88%4.19%3.03%
1 Month Performance-9.40%0.25%4.65%1.91%
1 Year Performance-52.33%14.35%35.15%16.34%

AVANOS MEDICAL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVNS
AVANOS MEDICAL
1.6676 of 5 stars
$10.74
-0.5%
N/A-52.4%$500.68M$687.80M-1.072,227High Trading Volume
EYE
National Vision
2.8221 of 5 stars
$25.07
+3.6%
$24.18
-3.5%
+118.9%$1.91B$1.82B-75.9713,411Positive News
LMAT
LeMaitre Vascular
2.2164 of 5 stars
$84.36
+4.1%
$97.83
+16.0%
+14.9%$1.83B$219.86M42.61490Insider Trade
CNMD
CONMED
3.9773 of 5 stars
$53.46
+2.2%
$59.80
+11.9%
-17.8%$1.62B$1.31B15.153,900News Coverage
Dividend Announcement
LQDA
Liquidia Technologies
3.0199 of 5 stars
$19.48
+10.2%
$26.89
+38.0%
+89.6%$1.51B$14M-12.3350Trending News
Earnings Report
Analyst Forecast
Options Volume
Gap Up
ENOV
Enovis
3.9157 of 5 stars
$26.61
+3.4%
$55.60
+109.0%
-31.6%$1.47B$2.11B-1.917,367Earnings Report
Analyst Revision
AORT
Artivion
3.1225 of 5 stars
$32.06
+3.7%
$32.40
+1.1%
+74.5%$1.32B$388.54M-64.121,600Earnings Report
Analyst Downgrade
CDRE
Cadre
1.5201 of 5 stars
$33.09
+2.3%
$37.50
+13.3%
-11.7%$1.31B$567.56M34.832,284Trending News
Analyst Downgrade
Analyst Revision
NVCR
NovoCure
4.4291 of 5 stars
$11.76
+3.9%
$28.79
+144.8%
-36.1%$1.27B$605.22M-7.541,488
SSII
SS Innovations International
N/A$6.57
+6.0%
N/AN/A$1.20B$20.65M0.004Gap Up
ESTA
Establishment Labs
2.1189 of 5 stars
$42.72
+3.3%
$54.83
+28.4%
-9.6%$1.20B$166.02M-13.781,018Earnings Report

Related Companies and Tools


This page (NYSE:AVNS) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners